Particpants were divided into groups based on doses of rosuvastatin and were assessed and for CPK, LDL and AST levels
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
195
a dose of 5mg were given and were compared for the cpk, ast and ldl levels
a dose of 10 mg were given and were compared for the cpk, ast and ldl levels
a dose of 20 mg were given and were compared for the cpk, ast and ldl levels
Central Park Teaching Hospital
Lahore, Pakistan
impact of rosuvstatin over LDL, CPK and AST levels
Pre- and post intervention levels of fasting serum low-density lipoprotein (LDL) in mg/dL were recorded and were compared in all study groups for assessment of the impact of various doses of rosuvastatin.
Time frame: 12 weeks
impact of rosuvstatin over LDL, CPK and AST levels
Pre- and post-intervention levels of creatine phosphokinase (CPK) in mcg/L were recorded and were compared in all study groups for assessment of the impact of various doses of rosuvastatin in terms of rhabdomyolysis.
Time frame: 12 weeks
impact of rosuvstatin over LDL, CPK and AST levels
Pre- and post-intervention levels of Aspartate Aminotransferase (AST) in U/L were recorded and were compared in all study groups for assessment of the impact of various doses of rosuvastatin in terms of liver damage.
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.